🎙️ Oncology Here & Now Podcast | Season 2, Episode 3

In this episode, we explore HER2-positive advanced breast cancer with a leading experts in the field Dr. Elisa Agostinetto and Dr. Erika Hamilton. We discuss the evolving treatment landscape, including first-line standards like the CLEOPATRA regimen and the latest DestinyBreast09 results from ASCO, and practical strategies for patient selection and toxicity management in daily clinical practice.
Key topics covered in this episode:

– Current standard of care for HER2+ ABC
– Impact of DestinyBreast09 results: Should T-DXd + pertuzumab be used for all patients or select patients?
 – Optimal treatment duration: induction vs maintenance strategies
– Monitoring ILD: CT scan frequency and best practices
– T-DXd rechallenge after grade 1 ILD: real-world insights

This episode is a must-listen for oncologists, hematologists, and healthcare professionals seeking practical guidance to improve patient care in HER2+ advanced breast cancer.

🔔 Subscribe for weekly episodes and stay updated on the latest in oncology